SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Motilal Oswal initiates Symbiotec Pharmalab at buy

Motilal Oswal initiated coverage of India's Symbiotec Pharmalab with a buy rating.

Related stories